Lyme disease is a tick-borne illness that can have serious health consequences if left undiagnosed and untreated. Early detection plays a vital role in managing this disease effectively and preventing long-term complications. Lyme disease screening is a valuable tool that can identify the presence of antibodies associated with the disease at an early stage. Let’s explore the benefits of early detection through The Mayo Clinic Lyme disease screening (SLYME) and how it can positively impact an individual's health outcomes.
Lyme Antibody Modified 2-Tier with Reflex (SLYME) is a diagnostic test used for screening and confirming Lyme disease. SLYME helps healthcare professionals assess antibody response and aid in early detection and appropriate treatment of Lyme disease. Here are the benefits of early detection.
Click here to view a sample SLYME screening report:
Lyme Disease (SLYME)
Early detection through Lyme Antibody Modified 2-Tier with Reflex (SLYME) offers numerous benefits, including prompt treatment initiation, prevention of chronic Lyme disease, minimizing health complications, personalized treatment plans, and peace of mind. If you live in an area prone to Lyme disease or engage in activities that increase your risk of tick bites, consider discussing Lyme disease screening with your healthcare provider. By prioritizing early detection, you can take proactive steps to protect your health and well-being, ensuring timely treatment and reducing the potential impact of Lyme disease on your life. Remember, early detection is key when it comes to managing Lyme disease effectively.
Health Today is a multi-disciplinary clinic designed to deliver competent, convenient access to health and wellness services in a timely fashion. We are committed to empowering our community to take control of their own comprehensive health and wellness by making access to the best resources for prevention, diagnosis, and care easy and affordable. If you have any questions regarding the advanced private lab tests available, connect with our Health Today team today. To book your Lyme Antibody Modified 2-Tier with Reflex (SLYME) or any other private lab services read our booking instructions and then book your advanced lab services.
The SLYME test involves two stages. First, an enzyme immunoassay (EIA) is performed to detect Lyme disease antibodies. If the EIA results are positive or equivocal, a Western blot test is conducted to confirm the presence of antibodies.
The two-tiered approach helps improve the accuracy of Lyme disease diagnosis. The initial EIA is a sensitive screening test, and the Western blot provides specific confirmation. This two-step process helps minimize false-positive results and ensures more reliable detection.
SLYME testing allows for early detection of Lyme disease, enabling prompt treatment initiation. It helps identify individuals at risk, facilitates targeted preventive measures, and reduces the likelihood of long-term complications associated with untreated Lyme disease. SLYME testing provides valuable information for personalized care and peace of mind.